| Application no. and date | 16823529.9 (espacenet) (Federated) (European Patent Register), 20161222 | | Patent/reg. no. and date | DK/EP 3394057, 20220330 | | Publication date | 20181031 | | Priority no. and date | US 201562387442 P, 20151223 | | EP pub. no. and date |
EP 3394057 20181031 | | Effective date | | | Applicant/owner | NEUROCRINE BIOSCIENCES, INC., 12780 El Camino Real
San Diego, CA 92130, US | | Applicant ref. no. | V440433DK00 | | Inventor | LI, Bin-Feng, A5-4F BioBay 218 Xinghu Street
Suzhou Industrial Park 215123, CN,
MCGEE, Kevin, 82663 Marlow Road
Eugene, OR 97405, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | C07D 471/04 (2006.01) | | Title | Syntetisk fremgangsmåde til fremstilling af (S)-(2R,3R,11BR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11B-hexahydro-1H-pyrido[2,1,-A]isoquinolin-2-yl
2-amino-3-methylbutanoat-di(4-methylbenzensulfonat) | | Int. application no. | US2016068277 | | Int. publication no. | WO2017112857 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
